These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10591692)

  • 1. Improving reperfusion after myocardial infarction.
    Menown IB; Adgey AA
    BMJ; 1999 Dec; 319(7224):1513-5. PubMed ID: 10591692
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycoprotein IIb/IIIa Inhibition as an adjunct to rescue angioplasty after failed fibrinolysis.
    Sallach JA; Greenbaum AB
    J Thromb Thrombolysis; 2001 Feb; 11(1):5-9. PubMed ID: 11248785
    [No Abstract]   [Full Text] [Related]  

  • 3. Overview of the use of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction.
    Joseph A
    J Emerg Med; 1999; 17(3):567-73. PubMed ID: 10338258
    [No Abstract]   [Full Text] [Related]  

  • 4. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Pereira H;
    Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycoprotein IIb/IIIa antagonists: an attractive new approach to reperfusion in acute myocardial infarction.
    Gambhir DS
    Indian Heart J; 1999; 51(3):259-60, 309. PubMed ID: 10624062
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myocardial infarction: early strategies to optimize results.
    J Invasive Cardiol; 2005 May; 17(5):288-91. PubMed ID: 15879613
    [No Abstract]   [Full Text] [Related]  

  • 7. Reperfusion in acute myocardial infarction: current concepts.
    Katritsis D; Karvouni E; Webb-Peploe MM
    Prog Cardiovasc Dis; 2003; 45(6):481-92. PubMed ID: 12800129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute reperfusion strategies for ST-segment elevation myocardial infarction.
    Glover BM; Adgey AA
    Eur Heart J; 2008 Mar; 29(5):571-2. PubMed ID: 18310670
    [No Abstract]   [Full Text] [Related]  

  • 9. GP IIb/IIIa inhibition in primary stenting: 'do it early, make it easy'.
    Montalescot G
    Eur Heart J; 2002 Feb; 23(4):259-60. PubMed ID: 11812056
    [No Abstract]   [Full Text] [Related]  

  • 10. Facilitated percutaneous coronary intervention: validating the open artery hypothesis.
    Runyon JP
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():22B-26B. PubMed ID: 10731296
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial salvage after reduced-dose thrombolysis combined with glycoprotein IIb/IIIa blockade versus thrombolysis alone in patients with acute myocardial infarction.
    Ndrepepa G; Mehilli J; Schwaiger M; Nekolla S; Schmitt C; Dirschinger J; Schömig A; Kastrati A
    J Thromb Thrombolysis; 2004 Jun; 17(3):191-7. PubMed ID: 15353917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining glycoprotein blockers with fibrinolysis: a bold stroke?
    Verheugt FW
    Eur Heart J; 2003 Oct; 24(20):1801-3. PubMed ID: 14563337
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of platelet glycoprotein IIb/IIIa receptor antagonists during the acute phase of myocardial infarction.
    van den Brand M; Ronner EF
    Semin Interv Cardiol; 1999 Jun; 4(2):85-8. PubMed ID: 10473877
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of angioplasty with stenting in acute myocardial infarction.
    Herrmann HC
    N Engl J Med; 2002 Aug; 347(5):367-8; author reply 367-8. PubMed ID: 12151478
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intracoronary thrombolysis combined with platelet receptor IIb/IIIa inhibitor and followed by percutaneous coronary intervention for the treatment of acute myocardial infarction: two case reports].
    Bryniarski L; Jankowski P; Dragan J; Dudek D; Kawecka-Jaszcz K
    Kardiol Pol; 2004 Mar; 60(3):255-9. PubMed ID: 15156222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glycoprotein IIb/IIIa receptor antagonists for improving thrombolytic and interventional therapy in patients with acute myocardial infarct].
    Zeymer U; Neuhaus KL
    Dtsch Med Wochenschr; 2000 Oct; 125(43):1297-300. PubMed ID: 11098229
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
    Ferreira D
    Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.
    Martínez-Ríos MA; Rosas M; González H; Peña-Duque MA; Martínez-Sánchez C; Gaspar J; García H; Gaxiola E; Delgado L; Carrillo J; Leyva JL; Lupi E;
    Am J Cardiol; 2004 Feb; 93(3):280-7. PubMed ID: 14759375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early reperfusion and aborted myocardial infarction].
    Furman NV; Dovgalevskiĭ IaP; Shchetinkina IN
    Kardiologiia; 2009; 49(11):89-92. PubMed ID: 20001988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
    Chew DP; Moliterno DJ; Herrmann HC
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.